SCHEMBL26309130

SCHEMBL26309130

Cc1c(Nc2cccc(NC(=O)c3ccc(Nc4ccncc4)cc3)c2)ccnc1C#N

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DNMT1 P26358 4/20 0.52
▸ DNMT3A Q9Y6K1 4/20 0.52
▸ KCNK3 O14649 2/20 0.47
▸ KCNK9 Q9NPC2 1/20 0.47
▸ DNMT3L Q9UJW3 2/20 0.47
▸ ABL1 P00519 3/20 0.46
▸ BCR P11274 3/20 0.46
▸ PDGFRB P09619 2/20 0.46
▸ PDGFRA P16234 2/20 0.46
▸ PRKCA P17252 2/20 0.46
▸ BRAF P15056 3/20 0.46
▸ MAPT P10636 2/20 0.46
▸ USP2 O75604 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ POLB P06746 1/20 0.45
▸ SRC P12931 1/20 0.44
▸ PRKCD Q05655 1/20 0.44
▸ CCNT1 O60563 1/20 0.43
▸ CCNE1 P24864 1/20 0.43
▸ CDK2 P24941 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26315265 0.87 DNMT1 (0.49) DNMT1DNMT3AKCNK3KCNK9DNMT3L
SCHEMBL24003860 0.85 DNMT1 (0.49) DNMT1DNMT3AKCNK3DNMT3LABL1
SCHEMBL30232699 0.85 DNMT1 (0.49) DNMT1DNMT3AKCNK3DNMT3LABL1
SCHEMBL30287679 0.85 DNMT1 (0.54) DNMT1DNMT3AKCNK3KCNK9DNMT3L
SCHEMBL30232520 0.85 DNMT1 (0.54) DNMT1DNMT3AKCNK3KCNK9DNMT3L
SCHEMBL24003828 0.85 DNMT1 (0.54) DNMT1DNMT3AKCNK3KCNK9DNMT3L
SCHEMBL24006113 0.85 DNMT1 (0.54) DNMT1DNMT3AKCNK3KCNK9DNMT3L
SCHEMBL24003830 0.82 KCNK3 (0.53) DNMT1DNMT3AKCNK3KCNK9ABL1
SCHEMBL30232513 0.82 KCNK3 (0.53) DNMT1DNMT3AKCNK3KCNK9ABL1
SCHEMBL24004056 0.81 KCNK3 (0.57) DNMT1DNMT3AKCNK3KCNK9DNMT3L

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295114-A1 AKT3 MODULATORS Georgiamune Inc. 2023-09-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295114-A1 AKT3 MODULATORS AKT3, AKT2, MTOR DNMT1 4758/4885DNMT3A 4679/4885KCNK3 2395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback